GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 135 filers reported holding GOSSAMER BIO INC in Q4 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $174,128 | +46.4% | 209,088 | +111.0% | 0.15% | +66.3% |
| Q2 2023 | $118,906 | +95024.8% | 99,088 | 0.0% | 0.09% | -9.2% |
| Q1 2023 | $125 | -41.9% | 99,088 | 0.0% | 0.10% | -35.5% |
| Q4 2022 | $215 | -100.0% | 99,088 | -37.7% | 0.15% | -88.7% |
| Q3 2022 | $1,906,000 | +43.1% | 159,088 | 0.0% | 1.34% | +38.5% |
| Q2 2022 | $1,332,000 | +18.9% | 159,088 | +23.2% | 0.97% | +20.2% |
| Q1 2022 | $1,120,000 | -1.0% | 129,088 | +29.1% | 0.81% | +10.6% |
| Q4 2021 | $1,131,000 | +124.9% | 100,000 | +150.0% | 0.73% | +113.2% |
| Q3 2021 | $503,000 | +7.2% | 40,000 | +33.3% | 0.34% | +0.3% |
| Q4 2019 | $469,000 | – | 30,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |